SIGNIFICANCE OF BLEEDING COMPLICATIONS ON ECULIZUMAB PK/PD IN PEDIATRIC PATIENTS WITH STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA).

被引:0
|
作者
Mizuno, K. [1 ]
Vinks, A. A. [1 ,2 ]
Dandoy, C. E. [1 ]
Teusink--Cross, A. [2 ]
Davies, S. [1 ]
Jodele, S. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PT21-001
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [31] RISK FACTORS FOR TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) AMONG PATIENTS WITH PHILADELPHIA POSITIVE (PH plus ) LEUKEMIAS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT
    Punatar, Sachin
    Kumbhalwar, Komal
    Kalantri, Siddhesh
    Gokarn, Anant
    Nayak, Lingaraj
    Chichra, Akanksha
    Mirgh, Sumeet
    Jindal, Nishant
    Mathew, Libin
    Kannan, Sadhana
    Khattry, Navin
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 515 - 515
  • [32] End Organ Damage Following Refractory/Recurrent Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Pediatric Patients Undergoing Autologous Hematopoietic Cell Transplantation
    Schoettler, Michelle Long
    Lehmann, Leslie E.
    Margossian, Steven
    Li, Anran
    Ma, Clement
    Duncan, Chrstine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [33] Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy
    Vasu, S.
    Wu, H.
    Satoskar, A.
    Puto, M.
    Roddy, J.
    Blum, W.
    Klisovic, R.
    Andritsos, L.
    Hofmeister, C.
    Benson, D. M.
    Efebera, Y.
    Jaglowski, S.
    Penza, S.
    Cohen, D.
    Devine, S.
    Cataland, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1241 - 1244
  • [34] Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
    Gomez-Ganda, Laura
    Benitez-Carabante, Maria Isabel
    Fernandez-Polo, Aurora
    Munoz-Lopez, Marina
    Renedo-Miro, Berta
    Ariceta, Gema
    Diaz De Heredia, Cristina
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [35] Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy
    S Vasu
    H Wu
    A Satoskar
    M Puto
    J Roddy
    W Blum
    R Klisovic
    L Andritsos
    C Hofmeister
    D M Benson
    Y Efebera
    S Jaglowski
    S Penza
    D Cohen
    S Devine
    S Cataland
    Bone Marrow Transplantation, 2016, 51 : 1241 - 1244
  • [36] Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy
    Schoettler, Michelle L.
    Lehmann, Leslie
    Kao, Pei -Chi
    Chen, Nan
    Jodele, Sonata
    Chonat, Satheesh
    Williams, Kirsten M.
    London, Wendy B.
    Duncan, Christine
    Dandoy, Christopher
    BLOOD ADVANCES, 2024, 8 (05) : 1220 - 1233
  • [37] ECULIZUMAB DOSING STRATEGIES IN PEDIATRIC PATIENTS WITH STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY: PHARMACOKINETIC/PHARMACODYNAMIC MODEL-BASED ASSESSMENT.
    Mizuno, K.
    Jodele, S.
    Dixon, B. P.
    Kathman, T.
    Block, M.
    Teusink-Cross, A.
    Davies, S. M.
    Vinks, A. A.
    Fukuda, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S26 - S26
  • [38] Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC
    de Fontbrune, Flore Sicre
    Galambrun, Claire
    Sirvent, Anne
    Anne Huynh
    Faguer, Stanislas
    Stephanie Nguyen
    Bay, Jacques-Olivier
    Neven, Benedicte
    Moussi, Julie
    Simon, Laurence
    Xhaard, Alienor
    Resche-Riggon, Matthieu
    O'Meara, Alix
    Fremeaux-Bacchi, Veronique
    Veyradier, Agnes
    Socie, Gerard
    Coppo, Paul
    de Latour, Regis Peffaut
    TRANSPLANTATION, 2015, 99 (09) : 1953 - 1959
  • [39] ECULIZUMAB DOSING STRATEGIES IN PEDIATRIC PATIENTS WITH STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY: PHARMACOKINETIC/ PHARMACODYNAMIC MODEL-BASED ASSESSMENT.
    Mizuno, K.
    Jodele, S.
    Dixon, B. P.
    Kathman, T.
    Block, M.
    Teusink-Cross, A.
    Davies, S. M.
    Vinks, A. A.
    Fukuda, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S120 - S121
  • [40] Transient elevation of plasma C5b-9 is not related to transplant-associated thrombotic microangiopathy (TA-TMA) in children treated with allogeneic hematopoietic stem cell transplantation (alloHSCT)
    Borsa, Nicolo' Ghiringhelli
    Taylor, Amanda
    Jones, Michael
    Zhang, Yuzhou
    Nester, Carla
    Smith, Richard J. H.
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2303 - 2303